Tumor-secreted Vascular Permeability Factor/Vascular Endothelial Growth Factor Influences Photosensitizer Uptake

Cancer Research

Volumn 53, Issue 1, 1993, Pages 153-157

  Gregory Roberts, W ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; DEXTRAN; EVANS BLUE; FLUORESCEIN; TETRASULFOPHTHALOCYANINE CHLOROALUMINUM; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; BLOOD VESSEL PERMEABILITY; BREAST CARCINOMA; CONTRAST MEDIUM EXTRAVASATION; DRUG ACCUMULATION; DRUG RETENTION; DRUG UPTAKE; EXPERIMENTAL NEOPLASM; GUINEA PIG; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR VASCULARIZATION;

ANIMAL; BLADDER NEOPLASMS; CAPILLARY PERMEABILITY; COMPARATIVE STUDY; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL GROWTH FACTORS; EVANS BLUE; GUINEA PIGS; HEPARIN; INDOLES; LYMPHOKINES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLCHOLANTHRENE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIZING AGENTS; RHABDOMYOSARCOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0027463410     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fingar, V. H. Wieman, T. J. and Doak, K. W. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res. 50: 2599-2603, 1990.
2. Reed, M. W. R. Wieman, T. J. Doak, K. W. Pietsch, C. G. and Schuschke, D. A. The microvascular effects of photodynamic therapy: evidence for a possible role of cy-clooxygenase products. Photochem. Photobiol. 50: 419-423, 1989.
3. Henderson, B. W. Waldow, S. M. Mang, T. S. Potter, W. R. Malone, P. B. and Dougherty, T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 45: 572-576, 1985.
4. Jain, R. K. Transport of macromolecules in tumor microcirculation. Biotechnol. Prog. /: 81-94, 1985.
5. White, L. Gomer, C. J. Doiron, D. R. and Szirth, B. C. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Br. J. Cancer, 57: 455-458, 1988.
6. Skinner, S. A. Tutton, P. J. M. and O'Brien, P. E. Microvascular architecture of experimental colon tumors in the rat. Cancer Res. 50: 2411-2417, 1990.
7. Jain, R. K. Transport of molecules in the tumor interstitium: a review. Cancer Res. 47: 3039-3051, 1987.
8. Jain, R. K. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst. 81: 570-576, 1989.
9. Gumkowski, E. Kaminska, G. Kaminski, M. Morrissey, L. W. and Auerbach, R. Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells. Blood Vessels, 24: 11-23, 1987.
10. Dvorak, H. F. Nagy, J. A. Dvorak, J. T. and Dvorak, A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133: 95-109, 1988.
11. Sands, H. Jones, P. L. Shah, S. A. Palme, D. Vessclla, R. L. and Gallagher, B. M. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenography Cancer Res. 48: 188-193, 1988.
12. Senger, D. R. Peruzzi, C. A. Feder, J. and Dvorak, H. F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46: 5629-5632, 1986.
13. Senger, D. R. Connolly, D. T. Van De Water, L. Feder, J. and Dvorak, H. F. Purification and NH2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor. Cancer Res. 50: 1774-1778, 1990.
14. Keck, P. J. Hauser, S. D. Krivi, G. etal. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.
15. Senger, D. R. Galli, S. J. Dvorak, A. M. Perruzzi, C. A. Harvey, V. S. and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
16. Ferrara, N. Houck, K. Jakeman, L. and Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13: 18-32, 1992.
17. Connolly, D. T. Heuvelman, D. M. Nelson, R. et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84: 1470-1478, 1989.
18. Criscuolo, G. R. Merrill, M. J. and Oldfield, E. H. Further characterization of malignant glioma-derived vascular permeability factor. J. Neurosurg. 69: 254-262, 1988.
19. Rosenthal, R. A. Megyesi, J. F. Henzel, W. J. Ferrara, N. and Folkman, J. Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors, 4: 53-59, 1990.
20. Rutledge, J. C. Curry, F.-R. E. Lenz, J. F. and Davis, P. A. Low density lipoprotein transport across a microvascular endothelial barrier after permeability is increased. Circ. Res. 66: 486-95, 1990.
21. Lynch, J. J. Ferro, T. J. Blumenstock, F. A. Brockenauer, A. M. and Malik, A. B. Increased endothelial albumin permeability mediated by protein kinase C activation. J. Clin. Invest. 85: 1991-1998, 1990.
22. Kongshaug, M. Distribution of tetrapyrrole photosensitizers among human plasma proteins. Int. J. Biochem. 24: 1239-1265, 1992.
23. Barel, A. Jori, G. Perm, A. Romandini, P. Pagnan, A. and Biffanti, S. Role of high, low and very low-density lipoproteins in the transport and tumor-delivery of hemato-porphyrin in vivo. Cancer Lett. 32: 145-150, 1986.
24. Roberts, W. G. and Hasan, T. Role of neovasculature and vascular permeability in the retention of photodynamic agents. Cancer Res. 52: 924-930, 1992.
25. Roberts, W. G. Smith, K. M. McCullough, J. L. and Berns, M. W. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photo-chem. Photobiol. 49: 431-438, 1989.
26. Miles, A. A. and Miles, E. M. Vascular reactions to histamine, histamine-liberator and lfMilfntaYinf in th ckin rf oninpa-niac I Phvcinl (\ rtnH) lift’ 99ft-9S7 1QS9 IwUKUIcIAIIIw III UIC alWIll VI KulllCa UIk5 S. rllYalUI. \iJli\I.J9 110.
27. Udaka, K. Takeuchi, Y. and Movat, H. Z. Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. Med. 133: 1384-1387, 1970.
28. Dougherty, T. J. Potter, W. R. and Bellnier, D. Photodynamic therapy for the treatment of cancer: current status and advances. In: D. Kessel (ed.), Photodynamic therapy of Neoplastic Disease, pp. 1-20. Boca Raton, FL: CRC Press, 1991.
29. Nelson, J. S. Wright, W. H. and Berns, M. W. Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer-enhanced digital video fluorescence microscopy. Cancer Res. 45: 5781-5786, 1985.
30. Gluckman, J. L. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a five year experience. Laryngoscope, 101: 36-41, 1991.
31. Henderson, B. W. and Fingar, V. H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47: 3110- 3114, 1987.
32. Nelson, J. S. Liaw, L.-H. Orenstein, A. Roberts, W. G. and Berns, M. W. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J. Natl. Cancer Inst. 80: 1599-1605, 1988.
33. Gomer, C. J. Rucker, N. and Wong, S. Porphyrin photosensitivity in cell lines expressing a heat-resistant phenotype. Cancer Res. 50: 5365-5368, 1990.
34. Singh, G. Wilson, B. C. Sharkey, S. M. Browman, G. P. and Deschamps, P. Resistance to photodynamic therapy in radiation induced fibrosarcoma-1 and Chinese hamster ovary-multi-drug resistant cells in vitro. Photochem. Photobiol. 54: 307-312, 1991.
35. Rosenthal, I. Phthalocyanines as photodynamic sensitizers. Photochem. Photobiol. 53: 859-870, 1991.
36. Tralau, C. J. Young, A. R. Walker, N. P. J. et al. Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminum sulphonated phthalocyanine (Al-SPc): a comparative study. Photochem. Photobiol. 49: 305-312, 1989.
37. Roberts, W. G. Klein, M. K. Loomis, M. Weldy, S. and Berns, M. W. Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloroaluminum sulfonated phthalocyanine. J. Natl. Cancer Inst. 83: 18-23, 1991.
38. Biolo, R. Jori, G. Kennedy, J. C. et al. A comparison of fluorescence methods used in the pharmacokinetic studies of Zn(II) phthalocyanine in mice. Photochem. Photobiol. 53: 113-118, 1991.
39. Green, T. P. Johnson, D. E. Marchessault, R. P. and Gatto, C. W. Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J. Lab. Clin. Med. ///: 173-183, 1988.
40. Shockley, T. R. Lin, K. Nagy, J. A. Tompkins, R. G. Yarmush, M. L. Dvorak, H. F. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res. 52: 367-376, 1992.